Stay updated on Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.

Latest updates to the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe page revision updated from v3.5.3 to v3.5.4. This indicates a minor maintenance update to the page version rather than a substantive alteration to the study details or displayed information.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe change updates the ClinicalTrials.gov page revision/version indicator from v3.5.2 to v3.5.3, reflecting a software or site release rather than an alteration to the study details.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.0%

- Check61 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No visible changes to study content or page layout are indicated by the screenshots.SummaryDifference0.0%

- Check68 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check96 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and the earlier Revision: v3.4.1 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.